A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott Freeman, MD
ACT Biotech, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Germans Trias I Pujol
Barcelona, Spain
- Hospital Vall D' Hebron
Barcelona, Spain
- Hospital Clinico San Carlos
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Ramon Y Cajal
Madrid, Spain
- Hospital Universitario Marques de Valdecilla
Santander, Spain
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Central Georgia Cancer Care, P.C.
Macon, Georgia, United States
- University of Pennsylvania, Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- the West Clinic
Memphis, Tennessee, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Oct 2011
- Completion
- 31 Jan 2012
- Last update posted
- 8 Feb 2012
- Registered enrollment
- 48
- Registry id
- NCT00952497
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.